by palligoelme@gmail.com | Mar 13, 2026 | Clinical Trials
Conditions: Neuroendocrine (NE) Tumors Interventions: Other: quality of life questionnaire, treatment side effect follow up Sponsors: Gustave Roussy, Cancer Campus, Grand Paris Not yet recruiting Conditions: Neuroendocrine (NE) Tumors Interventions: Other: quality...
by palligoelme@gmail.com | Mar 13, 2026 | Clinical Trials
Conditions: Subacute Stroke; Stroke; Stroke (Subacute); Stroke Gait Rehabilitation Interventions: Behavioral: Split-Belt Treadmill Sponsors: University of Calgary Recruiting Conditions: Subacute Stroke; Stroke; Stroke (Subacute); Stroke Gait Rehabilitation...
by palligoelme@gmail.com | Mar 13, 2026 | Clinical Trials
Conditions: Glioma; Diffuse Glioma; Recurrent Gliomas Interventions: Drug: Oral Vorasidenib administered once daily for up to 12 treatment cycles (28 days per cycle) as IDH-targeted therapy in participants with recurrent or residual IDH-mutant diffuse glioma....
by palligoelme@gmail.com | Mar 13, 2026 | Clinical Trials
Conditions: Acculturative Stress; Mental Health Interventions: Behavioral: STRONG; Behavioral: Learning Collaborative Sponsors: University of Oregon Not yet recruiting Conditions: Acculturative Stress; Mental Health Interventions: Behavioral: STRONG; Behavioral:...
by palligoelme@gmail.com | Mar 12, 2026 | Clinical Trials
Conditions: Infertility Interventions: Behavioral: Levin’s conservative model- based nursing care Sponsors: Fayoum University; Menoufia University Completed Conditions: Infertility Interventions: Behavioral: Levin’s conservative model- based nursing care...
by palligoelme@gmail.com | Mar 12, 2026 | Clinical Trials
Conditions: Spinal Cord Injuries Interventions: Device: tsDCS+pDCS; Device: Low-level laser therapy Sponsors: Spaulding Rehabilitation Hospital; PathMaker Neurosystems Inc.; Erchonia Corporation Completed Conditions: Spinal Cord Injuries Interventions: Device:...